ConductScience.org, home

Paper14701780

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.

Vanhoefer U and 12 others. J Clin Oncol, 2004. Cited by 213 papers, by iCite.

Cite this record

ConductScience Library. Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. Papers, record 14701780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14701780

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
PubMed
Journal
J Clin Oncol
PubMed
Year
2004
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
213
iCite
Relative citation ratio, by iCite
4.47
iCite
Revised in PubMed
2022-03-31
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vanhoefer UUdo
2Tewes MMitra
3Rojo FFederico
4Dirsch OOlaf
5Schleucher NNorbert
6Rosen OOliver
7Tillner JJoachim
8Kovar AAndreas
9Braun AHAda H
10Trarbach TTanja
11Seeber SSiegfried
12Harstrick AAndreas
13Baselga JJosé

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antineoplastic AgentsMajor topic
ErbB ReceptorsMajor topic
NeoplasmsMajor topic
Adult
Aged
Antibodies, Monoclonal, Humanized
Cetuximab
Female
Fever
Headache
Humans
Male
Maximum Tolerated Dose
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.

PMIDTitleJournalYearIn PapersSource
32533228Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2).Strahlenther Onkol2020https://conductscience.org/library/papers/32533228PubMed
30805388Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model.Iran J Biotechnol2018https://conductscience.org/library/papers/30805388PubMed
29438365Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.Br J Cancer2018https://conductscience.org/library/papers/29438365PubMed
27494775Therapeutic targets and new directions for antibodies developed for ovarian cancer.MAbs2016https://conductscience.org/library/papers/27494775PubMed
26267324Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.Oncotarget2015https://conductscience.org/library/papers/26267324PubMed
26019442Gastric cancer and the epoch of immunotherapy approaches.World J Gastroenterol2015https://conductscience.org/library/papers/26019442PubMed
25806192EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy?Transl Lung Cancer Res2012https://conductscience.org/library/papers/25806192PubMed
25806155Cetuximab in non-small-cell lung cancer.Transl Lung Cancer Res2012https://conductscience.org/library/papers/25806155PubMed
25733832Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.Int J Nanomedicine2015https://conductscience.org/library/papers/25733832PubMed
25501029REAL-Select: full-length antibody display and library screening by surface capture on yeast cells.PLoS One2014https://conductscience.org/library/papers/25501029PubMed
25323095Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.Neurosurg Rev2015https://conductscience.org/library/papers/25323095PubMed
24929808Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.Eur Spine J2014https://conductscience.org/library/papers/24929808PubMed
23314653Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study.Support Care Cancer2013https://conductscience.org/library/papers/23314653PubMed
23300028EGFR-directed monoclonal antibodies in non-small cell lung cancer.Target Oncol2013https://conductscience.org/library/papers/23300028PubMed
23150825The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neck.Chemother Res Pract2012https://conductscience.org/library/papers/23150825PubMed
22832803A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer.Invest New Drugs2013https://conductscience.org/library/papers/22832803PubMed
22763610Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas.Invest New Drugs2013https://conductscience.org/library/papers/22763610PubMed
22754591Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer.Ther Adv Med Oncol2012https://conductscience.org/library/papers/22754591PubMed
22640435Cutting edge in medical management of cutaneous oncology.Semin Cutan Med Surg2012https://conductscience.org/library/papers/22640435PubMed
22253528Novel immunotherapeutic strategies of gastric cancer treatment.J Biomed Biotechnol2011https://conductscience.org/library/papers/22253528PubMed

See all 58 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14701780

GET https://conductscience.org/api/papers/v1/14701780/cited_by?page=2